206 related articles for article (PubMed ID: 22847784)
1. GEF-H1 over-expression in hepatocellular carcinoma promotes cell motility via activation of RhoA signalling.
Cheng IK; Tsang BC; Lai KP; Ching AK; Chan AW; To KF; Lai PB; Wong N
J Pathol; 2012 Dec; 228(4):575-85. PubMed ID: 22847784
[TBL] [Abstract][Full Text] [Related]
2. Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition.
Chung KY; Cheng IK; Ching AK; Chu JH; Lai PB; Wong N
Hepatology; 2011 Jul; 54(1):307-18. PubMed ID: 21520196
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of GEF-H1 promotes colon cancer progression by RhoA signaling.
Cao J; Yang T; Tang D; Zhou F; Qian Y; Zou X
Pathol Res Pract; 2019 May; 215(5):1012-1019. PubMed ID: 30846413
[TBL] [Abstract][Full Text] [Related]
4. ARHGEF10L contributes to liver tumorigenesis through RhoA-ROCK1 signaling and the epithelial-mesenchymal transition.
Tang J; Liu C; Xu B; Wang D; Ma Z; Chang X
Exp Cell Res; 2019 Jan; 374(1):46-68. PubMed ID: 30444969
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.
Tang DJ; Dong SS; Ma NF; Xie D; Chen L; Fu L; Lau SH; Li Y; Li Y; Guan XY
Hepatology; 2010 Apr; 51(4):1255-63. PubMed ID: 20112425
[TBL] [Abstract][Full Text] [Related]
6. Claudin-2 suppresses GEF-H1, RHOA, and MRTF, thereby impacting proliferation and profibrotic phenotype of tubular cells.
Dan Q; Shi Y; Rabani R; Venugopal S; Xiao J; Anwer S; Ding M; Speight P; Pan W; Alexander RT; Kapus A; Szászi K
J Biol Chem; 2019 Oct; 294(42):15446-15465. PubMed ID: 31481470
[TBL] [Abstract][Full Text] [Related]
7. Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway.
Chen X; Zhang S; Wang Z; Wang F; Cao X; Wu Q; Zhao C; Ma H; Ye F; Wang H; Fang Z
J Exp Clin Cancer Res; 2018 Jun; 37(1):128. PubMed ID: 29954442
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA.
Wang SC; Lin XL; Li J; Zhang TT; Wang HY; Shi JW; Yang S; Zhao WT; Xie RY; Wei F; Qin YJ; Chen L; Yang J; Yao KT; Xiao D
PLoS One; 2014; 9(7):e101330. PubMed ID: 24992599
[TBL] [Abstract][Full Text] [Related]
9. Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling.
Liao YC; Ruan JW; Lua I; Li MH; Chen WL; Wang JR; Kao RH; Chen JH
Oncogene; 2012 Jun; 31(25):3086-97. PubMed ID: 22002306
[TBL] [Abstract][Full Text] [Related]
10. ARHGEF11 promotes proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma through activation of β-catenin pathway.
Du J; Zhu Z; Xu L; Chen X; Li X; Lan T; Li W; Yuan K; Zeng Y
Aging (Albany NY); 2020 Oct; 12(20):20235-20253. PubMed ID: 33122451
[TBL] [Abstract][Full Text] [Related]
11. GEF-H1/RhoA signalling pathway mediates lipopolysaccharide-induced intercellular adhesion molecular-1 expression in endothelial cells via activation of p38 and NF-κB.
Guo F; Zhou Z; Dou Y; Tang J; Gao C; Huan J
Cytokine; 2012 Mar; 57(3):417-28. PubMed ID: 22226621
[TBL] [Abstract][Full Text] [Related]
12. Role of guanine nucleotide exchange factor-H1 in complement-mediated RhoA activation in glomerular epithelial cells.
Mouawad F; Aoudjit L; Jiang R; Szaszi K; Takano T
J Biol Chem; 2014 Feb; 289(7):4206-18. PubMed ID: 24356971
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathways that control rho kinase activity maintain the embryonic epicardial progenitor state.
Artamonov MV; Jin L; Franke AS; Momotani K; Ho R; Dong XR; Majesky MW; Somlyo AV
J Biol Chem; 2015 Apr; 290(16):10353-67. PubMed ID: 25733666
[TBL] [Abstract][Full Text] [Related]
14. Guanine nucleotide exchange factor-H1 regulates cell migration via localized activation of RhoA at the leading edge.
Nalbant P; Chang YC; Birkenfeld J; Chang ZF; Bokoch GM
Mol Biol Cell; 2009 Sep; 20(18):4070-82. PubMed ID: 19625450
[TBL] [Abstract][Full Text] [Related]
15. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
[TBL] [Abstract][Full Text] [Related]
16. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.
Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K
Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948
[TBL] [Abstract][Full Text] [Related]
17. Involvement of RhoA in progression of human hepatocellular carcinoma.
Wang D; Dou K; Xiang H; Song Z; Zhao Q; Chen Y; Li Y
J Gastroenterol Hepatol; 2007 Nov; 22(11):1916-20. PubMed ID: 17914970
[TBL] [Abstract][Full Text] [Related]
18. BNIP-2 retards breast cancer cell migration by coupling microtubule-mediated GEF-H1 and RhoA activation.
Pan M; Chew TW; Wong DCP; Xiao J; Ong HT; Chin JFL; Low BC
Sci Adv; 2020 Jul; 6(31):eaaz1534. PubMed ID: 32789168
[TBL] [Abstract][Full Text] [Related]
19. Reducing GEF-H1 Expression Inhibits Renal Cyst Formation, Inflammation, and Fibrosis via RhoA Signaling in Nephronophthisis.
Hu Q; Lai J; Chen H; Cai Y; Yue Z; Lin H; Sun L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834937
[TBL] [Abstract][Full Text] [Related]
20. GEF-H1-RhoA signaling pathway mediates LPS-induced NF-κB transactivation and IL-8 synthesis in endothelial cells.
Guo F; Tang J; Zhou Z; Dou Y; Van Lonkhuyzen D; Gao C; Huan J
Mol Immunol; 2012 Feb; 50(1-2):98-107. PubMed ID: 22226472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
